Skip to main content

Table 2 Pharmacokinetic parameters of lumefantrine after oral and intravenous administration in rats

From: Intravenous pharmacokinetics, oral bioavailability, dose proportionality and in situ permeability of anti-malarial lumefantrine in rats

Parameters

Intravenous

Per-oral

 

0.5 mg/kg

10 mg/kg

20 mg/kg

40 mg/kg

AUC 0-t (hr*ng/mL)

9,189.76 ± 1,372.42

21,294.02 ± 3,235.75

17,683.7 ± 3,168.23

38,248.94 ± 7,792.61

AUC 0-∞ (hr*ng/mL)

9,529.47 ± 1,283.18

22,025.48 ± 3,448.87

18,281.07 ± 3,062.84

39,958.71 ± 8,362.60

C max (ng/mL)

1,890 ± 330.61

1,488 ± 311.47

938.75 ± 370.64

2,280 ± 522.32

T max (hr)

-

8(2-8)

3.5(2-8)

5(2-8)

Vd (L/kg)

2.40 ± 0.67

-

-

-

CL (L/h/kg)

0.03 ± 0.02

-

-

-

t 1/2 (hr)

30.92 ± 4.81

36.08 ± 8.52

25.7 ± 1.85

38.23 ± 4.51

% F

-

11.56

4.80

5.24